The Nuestra Señora del Rosario Polyclinica in Ibiza, Spain. Image source.

Health Impact News Editor Comments

Spain joins the list of nations using non-pharmaceutical drugs successfully to cure COVID-19 patients, while such treatments are ignored in the corporate “mainstream” media.

Intravenous Vitamin C therapy and Ozone therapy are among the top non-pharmaceutical solutions seeing great results, both around the world and in the U.S.

The Nuestra Señora del Rosario Polyclinica in Ibiza is the first in Spain to use the Ozone technique in treating Covid-19 patients, with success.


In a press release the clinic said:

“Many patients who were about to be intubated and connected to mechanical ventilation have, thanks to ozone therapy, not only avoided it but improved to the point of not requiring oxygen with just a few treatment sessions.”

The clinic also stated that they are seeing improvements in patients after just ‘2 or 3 treatment sessions’. Ozone therapy has the benefit of improving oxygenation at the tissue level and therefore reduces the inflammatory response suffered by patients.

Italy and China Trial Ozone

At the Santa María della Misericordia University Hospital in Udine, Italy, 36 patients with Covid-19 pneumonia who had respiratory failure were administered Ozone therapy. Only 3% required intubation compared to the usual 15%. There is a high mortality of intubated patients and given a fifth were spared intubation; it is an achievement to highlight. There are also four clinical trials underway in China and the provisional results could not be more hopeful.

Nuestra Señora del Rosario Polyclinic

“In Spain, only we have begun to administer it with the mandatory authorisation of the Quality Committee of the hospital centre, and the results have been spectacular,” says Dr. Alberto Hernández, Assistant Physician for Anaesthesia and Resuscitation at the Nuestra Señora del Rosario Polyclinic in Ibiza.

“We have registered a clinical trial, but we need to tell the world that Ozone is a very effective and beneficial therapy in these patients and that we must immediately incorporate it into the treatment of these patients.”

Dr. José Baeza, President of the Spanish Society of Ozone Therapy and Vice President of the World Federation of Ozone Therapy, states that:

“Given the absence of an effective treatment or a vaccine and in the context of the current health emergency, all hospitalised patients should receive Ozone therapy as the clear benefit is evident, and Ozone therapy has no significant side effects.”


On April 4, the therapy was authorised for it’s first use at the Polyclinic.

After presenting the potential benefits of Ozone therapy at a medical scientific session, the centre’s group of experts in Covid-19 infection: Drs Montserrat Viñals and Asunción Pablos, from the Internal Medicine service, Dr. Adriana Martín from the Service of Intensive Medicine, and Dr. María Victoria Velasco from the Emergency Service of the Nuestra Señora del Rosario Polyclinica in Ibiza, gave their approval to the protocol for the administration of Ozone in patients with Covid-19 presented by Dr. Alberto Hernández.

The First Patient

A 49-year-old man who had already required ICU admission was deteriorating on the ward. He had deteriorated to the point that he required oxygen at the highest concentration and yet it was oxygenating his lungs poorly. Intubation and connection to a ventilator was planned, but surprisingly, after the first session of Ozone therapy, the improvement was significant and oxygen requirements could be decreased.

Dr. Alberto Hernández explained that:

“The improvement after the first session of Ozone treatment was spectacular. We were surprised, his respiratory rate normalised, his oxygen levels increased, and we were able to stop supplying him with as much oxygen since the patient was able to oxygenate himself.

To our surprise, when we carried out an analytical control, we observed how Ferritin, an analysis determination that is being used as a prognostic marker in this disease, not only had not followed the upward trend, but had decreased significantly; that decline continued in the following days. This result encouraged us to administer it to other patients who are following the same improvement as our first patient.”

We Will Help Other Hospitals

Dr. Hernández said:

“Let no one hesitate to contact us in order to establish the appropriate circuits and structure to be able to incorporate Ozone therapy as soon as possible in the different hospital centres that wish to do so.”

From the Polyclinic Group, Francisco Vilás, its CEO, pointed out that:

“We will be happy to contribute and help any hospital that asks us for help, in such exceptional circumstances as those we are experiencing that we can contribute to help in this unfortunate pandemic. Full of pride, we will make our human and technical resources and our experience with Ozone therapy available to those who request it.”